Acetazolamide
Acetazolamide is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Acetazolamide; Generic name: ACETAZOLAMIDE; Drug class: Carbonic Anhydrase Inhibitor [EPC].
| Brand name | Acetazolamide |
|---|---|
| Generic name | ACETAZOLAMIDE |
| Drug class | Carbonic Anhydrase Inhibitor [EPC] |
| Manufacturer | NuCare Pharmaceuticals,Inc. |
| Used for | INDICATIONS AND USAGE For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide Tablets are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent. |
| Dosage | DOSAGE AND ADMINISTRATION Glaucoma Acetazolamide should be used as an adjunct to the usual therapy. The dosage employed in the treatment of chronic simple (open-angle) glaucoma ranges from 250 mg to 1 g of acetazolamide per 24 hours, usually in divided doses for amounts over 250 mg. It has usually been found that a dosage in excess of 1 g per 24 hours does not produce an increased effect. In all cases, the dosage should be adjusted with careful individual attention both to symptomatology and ocu |
| Warnings | WARNINGS Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias. Sensitizations may recur when a sulfonamide is readministered irrespective of the route of administration. If signs of hypersensitivity or other serious reactions occur, discontinue use of this drug. Caution is advised for patients receiving concomitant |
| Active ingredient(s) | ACETAZOLAMIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b76c194-b244-e9ac-e063-6394a90a373e |